Aug 4, 2020 7:00am EDT Tonix Pharmaceuticals Announces that Results from a Preclinical Study of TNX-1900 are Posted at the AAN Sports Concussion Virtual Conference
Jul 30, 2020 7:00am EDT Tonix Pharmaceuticals to Participate in SNN Network Virtual Investor Conference
Jul 27, 2020 7:00am EDT Tonix Pharmaceuticals Announces that Results from a Preclinical Study of TNX-1900 Will be Presented in a Poster at the AAN Sports Concussion Virtual Conference
Jul 21, 2020 4:45pm EDT Tonix Pharmaceuticals Holding Corp. Announces Rescheduling of Special Meeting of Stockholders
Jul 16, 2020 9:00am EDT Tonix Pharmaceuticals Announces Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics
Jul 15, 2020 5:00pm EDT Tonix Pharmaceuticals Holding Corp. Closes $10.5 Million Common Stock Registered Direct Offering
Jul 13, 2020 7:00am EDT Tonix Pharmaceuticals Enters into Research and Exclusive License Option Agreement with Kansas State University to Develop Vaccine Against COVID-19
Jul 10, 2020 7:00am EDT Tonix Pharmaceuticals Completes Enrollment in Phase 3 RELIEF Trial of TNX-102 SL for Management of Fibromyalgia
Jul 7, 2020 7:00am EDT Tonix Pharmaceuticals Plans Massachusetts R&D Facility to Accelerate Clinical Development of Vaccines and Protein-Based Therapeutics
